半乳糖凝集素7(GAL7)活性蛋白
Active Galectin 7 (GAL7)
LGALS7; PIG1; TP53I1; HKL-14; Lectin Galactoside-Binding Soluble 7; p53-induced gene 1 protein
- 編號(hào)APA307Hu01
- 物種Homo sapiens (Human,人) 相同的名稱(chēng),不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)7.2
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 1469 ¥ 3672 ¥ 7344 ¥ 22032 ¥ 55080
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷(xiāo)商聯(lián)系!
活性實(shí)驗(yàn)
The galectins constitute a large family of carbohydrate-binding proteins with specificity for N-acetyl-lactosamine-containing glycoproteins. At least 14 mammalian galectins, which share structural similarities in their carbohydrate recognition domains (CRD), have been identified. The galectins have been classified into the prototype galectins (-1, -2, -5, -7, -10, -11, -13, -14), which contain one CRD and exist either as a monomer or a noncovalent homodimer; the chimera galectins (Galectin-3) containing one CRD linked to a nonlectin domain; and the tandem-repeat galectins (-4, -6, -8, -9, -12) consisting of two CRDs joined by a linker peptide. Galectin-7 may also be involved in cell-cell and cell-matrix interactions and exogenous galectin has been found to accelerate the re-epithelialization of wounds
It can agglutinate red blood.In this case, we chose rabbit erythrocyte (RaE) to assay its ability of agglutination. A general procedure for hemagglutination assay (or haemagglutination assay; HA) is as follows, two-fold dilute the recombinant human GAL7 with 0.9% sodium chloride injection, add 50μL a serial dilution of GAL7 to each well of a U or V-bottom shaped 96-well microtiter plate. The final well serves as a negative control with no GAL7, replace with 50μL 0.9% sodium chloride injection. Then add 50μL 1% rabbit erythrocyte to each well and mixed gently. The plate is incubated for 3 hours at room temperature. The results are shown in Figure 1. It was obvious that the minimal effective concentration of GAL7 is 6.25 μg/mL.
Figure 2. The hemagglutination assay of GAL7 in V- bottom shaped 96-well microtiter plate.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APA307Hu01 | 半乳糖凝集素7(GAL7)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA307Hu01 | 半乳糖凝集素7(GAL7)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA307Hu01 | 半乳糖凝集素7(GAL7)多克隆抗體 | WB |
LAA307Hu71 | 半乳糖凝集素7(GAL7)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAA307Hu21 | 半乳糖凝集素7(GAL7)單克隆抗體 | WB |
MAA307Hu23 | 半乳糖凝集素7(GAL7)單克隆抗體 | WB; IHC; ICC; IP. |
MAA307Hu24 | 半乳糖凝集素7(GAL7)單克隆抗體 | WB; IHC; ICC; IP. |
MAA307Hu25 | 半乳糖凝集素7(GAL7)單克隆抗體 | WB; IHC; ICC; IP. |
MAA307Hu26 | 半乳糖凝集素7(GAL7)單克隆抗體 | WB; IHC; ICC; IP. |
MAA307Hu22 | 半乳糖凝集素7(GAL7)單克隆抗體 | WB; IHC; ICC; IP. |
LAA307Hu72 | 半乳糖凝集素7(GAL7)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
SEA307Hu | 半乳糖凝集素7(GAL7)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA307Hu | 半乳糖凝集素7(GAL7)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
PSA307Hu01 | 半乳糖凝集素7(GAL7)抗體對(duì) | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
KSA307Hu01 | 半乳糖凝集素7(GAL7)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
CGA307Hu01 | 半乳糖凝集素7(GAL7)cDNA | PCR、蛋白表達(dá)等 |